Patents

US 12138296 B2: Formulations for bovine granulocyte colony stimulating factor and variants thereof

Granted
2024-11-12
Filed
2022-02-02 application 17591553
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

This invention provides stable aqueous formulations comprising a bG-CSF polypeptide or a variant thereof, a buffer substance, and an excipient, wherein said formulation is substantially free of polyoxyethylene (20) sorbitan monolaurate. The invention also provides methods of using, a lyophilized or powdered form of, and processes for, preparing the formulation.

Source: PVGPATDIS, file of 2026-04-10 (ipg241112.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Elanco US Inc. 52 patentsUS company or organizationGreenfield, INPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Alan KlotzIndianapolis, IN4PVGPATDIS, file of 2026-04-10
Catherine Ngan KhaRaleigh, NC2PVGPATDIS, file of 2026-04-10
Juan DavagninoDurham, NC3PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K38/193PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P29/00PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K14/535PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.